Friday, February 13, 2026
No menu items!
Solve Education Annual Report 2024
Hi,
HomeFeaturesIndustry InsightsSingapore's Science + China's Scale: Why APAC Biotech Winners Must Think Cross-border...

Singapore’s Science + China’s Scale: Why APAC Biotech Winners Must Think Cross-border Early

By Ritika KhetawatFounder, MissionBridge | Ex–Goldman Sachs, Ex–Morgan Stanley Singapore has built one of Asia’s strongest scientific foundations in biotechnology. World-class research institutions, globally trained scientists, and sustained government investment have created a discovery engine that rivals top global hubs. Yet in my work advising biotech founders, one question keeps resurfacing: why do so few...

Let's Stay Connected

Join thousands of readers who already enjoy exclusive content—sign up today. It's currently free!

Join Now

Already a member? Log in here
Ritika Khetawat
Ritika Khetawat
Ritika Khetawat is the Founder of MissionBridge Advisors, a strategic advisory firm supporting deeptech and biotech ventures in fundraising, M&A, and cross-border growth. With over a decade of experience in investment banking and startup fundraising, she has raised more than US$2 billion across Southeast Asia and India. Formerly Head of Corporate Development at Tessa Therapeutics, she helped secure over US$300 million from leading global investors and sovereign wealth funds. Ritika works closely with founders to design capital-efficient growth strategies in capital-intensive industries.
RELATED ARTICLES
- Advertisment -spot_img

Most Popular

Recent Comments